Persistence of Neisseria meningitidis in the upper respiratory tract after intravenous antibiotic therapy for systemic meningococcal disease.
D000293:Adolescent; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008585:Meningitis, Meningococcal / Q000188:drug therapy* / Q000382:microbiology; D008589:Meningococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D009305:Nasopharynx / Q000382:microbiology; D009345:Neisseria meningitidis / Q000254:growth & development*; D010406:Penicillins / Q000627:therapeutic use; D010614:Pharynx / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D010406:Penicillins; D002701:Chloramphenicol; D000667:Ampicillin